EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+1.73%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$8.15B
AUM Growth
-$196M
(-2.4%)
Cap. Flow
+$63.3M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
27.57%
Holding
907
New
39
Increased
187
Reduced
142
Closed
42
Top Buys
| 1 |
Dollar General
DG
|
$49.2M |
| 2 |
Abbott
ABT
|
$48.4M |
| 3 |
HES
Hess
HES
|
$47.1M |
| 4 |
Progressive
PGR
|
$40M |
| 5 |
Microsoft
MSFT
|
$31.2M |
Top Sells
| 1 |
Netflix
NFLX
|
$71.8M |
| 2 |
PACCAR
PCAR
|
$61.9M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$40.6M |
| 4 |
Biogen
BIIB
|
$34.5M |
| 5 |
Broadcom
AVGO
|
$29M |
Sector Composition
| 1 | Technology | 36.17% |
| 2 | Healthcare | 14.32% |
| 3 | Financials | 13.21% |
| 4 | Communication Services | 10.05% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
AGCO
AGCO
$8.28B
| $1.98M | 0.02% |
21,290
-3,484
| -14% | -$325K |
|
327
Waste Connections
WCN
$46.1B
| $1.95M | 0.02% |
11,354
+96
| +0.9% | +$16.5K |
|
328
Xenon Pharmaceuticals
XENE
$3.02B
| $1.94M | 0.02% |
50,000
| – | – |
|
329
Viking Therapeutics
VKTX
$3.03B
| $1.93M | 0.02% |
47,000
| – | – |
|
330
MINISO
MNSO
$7.49B
| $1.92M | 0.02% |
80,000
+40,000
| +100% | +$962K |
|
331
Biohaven
BHVN
$1.68B
| $1.88M | 0.02% |
51,300
| – | – |
|
332
AvalonBay Communities
AVB
$27.8B
| $1.88M | 0.02% |
8,500
+700
| +9% | +$155K |
|
333
Nasdaq
NDAQ
$53.6B
| $1.87M | 0.02% |
23,828
+16,153
| +210% | +$1.27M |
|
334
Ionis Pharmaceuticals
IONS
$9.76B
| $1.84M | 0.02% |
51,300
| – | – |
|
335
Repligen
RGEN
$7.01B
| $1.82M | 0.02% |
12,500
| – | – |
|
336
Zscaler
ZS
$42.7B
| $1.8M | 0.02% |
9,780
+56
| +0.6% | +$10.3K |
|
337
Match Group
MTCH
$9.18B
| $1.77M | 0.02% |
53,463
+5,792
| +12% | +$192K |
|
338
Equifax
EFX
$30.8B
| $1.74M | 0.02% |
+6,812
| New | +$1.74M |
|
339
Sun Life Financial
SLF
$32.4B
| $1.69M | 0.02% |
28,400
+200
| +0.7% | +$11.9K |
|
340
Parker-Hannifin
PH
$96.1B
| $1.67M | 0.02% |
2,600
-400
| -13% | -$258K |
|
341
MongoDB
MDB
$26.4B
| $1.67M | 0.02% |
+7,000
| New | +$1.67M |
|
342
Arcellx
ACLX
$4.03B
| $1.66M | 0.02% |
21,000
| – | – |
|
343
Passage Bio
PASG
$22.8M
| $1.63M | 0.02% |
122,790
| – | – |
|
344
Laureate Education
LAUR
$4.1B
| $1.62M | 0.02% |
89,186
| – | – |
|
345
Schlumberger
SLB
$53.4B
| $1.62M | 0.02% |
42,957
+4,680
| +12% | +$177K |
|
346
Colliers International
CIGI
$8.43B
| $1.62M | 0.02% |
12,000
| – | – |
|
347
Baidu
BIDU
$35.1B
| $1.56M | 0.02% |
18,033
| – | – |
|
348
Enbridge
ENB
$105B
| $1.55M | 0.02% |
36,900
-1,700
| -4% | -$71.2K |
|
349
Freeport-McMoran
FCX
$66.5B
| $1.54M | 0.02% |
39,600
-23,500
| -37% | -$911K |
|
350
Edwards Lifesciences
EW
$47.5B
| $1.47M | 0.02% |
19,494
| – | – |
|